Ascletis Pharma Inc.
General ticker "ASCLF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.4B (TTM average)
Ascletis Pharma Inc. follows the US Stock Market performance with the rate: 32.0%.
Estimated limits based on current volatility of 0.2%: low 2.12$, high 2.13$
Short-term ASCLF quotes
Long-term ASCLF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | CNY56.60MM | CNY1.28MM | CNY1.98MM |
| Operating Expenses | CNY356.80MM | CNY296.70MM | CNY473.25MM |
| Operating Income | CNY-300.21MM | CNY-295.42MM | CNY-471.27MM |
| Non-Operating Income | CNY155.49MM | CNY-5.52MM | CNY121.17MM |
| Interest Expense | CNY0.14MM | CNY0.00MM | CNY0.16MM |
| R&D Expense | CNY216.78MM | CNY302.39MM | CNY387.75MM |
| Income(Loss) | CNY-144.72MM | CNY-300.94MM | CNY-350.10MM |
| Taxes | CNY0.00MM | CNY0.00MM | CNY-0.49MM |
| Profit(Loss)* | CNY-144.72MM | CNY-300.94MM | CNY-350.59MM |
| Stockholders Equity | CNY2,342.07MM | CNY1,966.16MM | CNY1,935.24MM |
| Inventory | CNY6.07MM | CNY4.37MM | CNY1.87MM |
| Assets | CNY2,491.01MM | CNY2,124.57MM | CNY2,067.57MM |
| Operating Cash Flow | CNY-144.16MM | CNY-341.58MM | CNY-329.25MM |
| Capital expenditure | CNY19.16MM | CNY2.15MM | CNY1.60MM |
| Investing Cash Flow | CNY149.84MM | CNY978.91MM | CNY566.01MM |
| Financing Cash Flow | CNY-81.50MM | CNY-103.51MM | CNY336.32MM |
| Earnings Per Share** | CNY-0.13 | CNY-0.30 | CNY-0.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.